Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation

For relapsed acute myeloid leukemia (AML) patients who received allogeneic hematopoietic stem cell transplantation, donor lymphocyte infusion (DLI) is an effective therapy. However, the cell source of DLI remains a topic of debate. In this study, we aimed to compare the efficacy and safety of G-CSF...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Woochan, Byun, Ja Min, Hong, Junshik, Kim, Inho, Shin, Dong-Yeop, Park, Seonyang, Koh, Youngil, Yoon, Sung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977844/
https://www.ncbi.nlm.nih.gov/pubmed/36662278
http://dx.doi.org/10.1007/s00277-023-05093-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977844/
https://www.ncbi.nlm.nih.gov/pubmed/36662278
http://dx.doi.org/10.1007/s00277-023-05093-w

Ejemplares similares